The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from PR Newswire

IMRIS Inc. Announces Proposed Public Offering of Common Shares

Tuesday, March 12, 2013

IMRIS Inc. Announces Proposed Public Offering of Common Shares16:11 EDT Tuesday, March 12, 2013 WINNIPEG, March 12, 2013 /PRNewswire/ - IMRIS Inc. ("IMRIS" or the "Company") (NASDAQ: IMRS; TSX: IM) today announced that it has commenced an underwritten public offering of its common shares.  The offering is being conducted in the United States pursuant to the Company's effective shelf registration statement filed with the U.S. Securities and Exchange Commission (the "SEC") and in Canada pursuant to a final short form base shelf prospectus filed with the securities regulatory authorities in each of the provinces and territories of Canada, other than Quebec.  The number of common shares to be issued and the price of each common share will be determined at the time of pricing the proposed offering. Canaccord Genuity is acting as sole book-running manager for the proposed offering.  The Company expects to grant the underwriter a 30-day option to purchase up to an additional 15 percent of the number of common shares sold pursuant to the public offering solely to cover over-allotments, if any.  The proposed offering is subject to customary conditions, including the approval of the Toronto Stock Exchange and The NASDAQ Stock Market, and there can be no assurance as to whether or when the proposed offering may be completed, or as to the actual size or terms of the offering. The proposed offering will be made only by means of the prospectus supplement and the accompanying short form base shelf prospectus.  When available, copies of the preliminary prospectus supplement and the accompanying short form base shelf prospectus may be obtained upon request by contacting Canaccord Genuity Inc., Attention: Syndicate Department, 99 High Street, 12th Floor, Boston, Massachusetts 02110, or by telephone at (617) 371-3900.  Electronic copies of the preliminary prospectus supplement and the accompanying short form base shelf prospectus will also be available free of charge at www.sedar.com and www.sec.gov, respectively. This press release does not constitute an offer to sell or a solicitation of an offer to buy the securities described herein, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. About IMRIS IMRIS Inc. (NASDAQ: IMRS; TSX: IM) is a global leader in providing image guided therapy solutions through its VISIUS Surgical Theatre - a revolutionary, multifunctional surgical environment that provides intraoperative vision to clinicians to assist in decision making and enhance precision in treatment. VISIUS Surgical Theatres serve the neurosurgical, cardiovascular and cerebrovascular markets and have been selected by leading medical institutions around the world. For more information, visit www.imris.com Forward-Looking Statements This press release may contain or refer to certain information that may constitute "forward-looking information" and "forward-looking statements" within the meaning of applicable Canadian and United States securities laws. These statements are based upon assumptions that the proposed offering will be successfully completed on the terms described above. There can be no assurance that IMRIS will complete the proposed offering. All statements relating to plans, strategies, projections of results of specific activities or investments, and other statements that are not descriptions of historical facts may be forward-looking statements. Forward-looking statements and information are inherently subject to risks and uncertainties, and actual results could differ materially from those currently anticipated due to a number of factors, which include, but are not limited to, operational risks, the effects of general economic conditions, changing foreign exchange rates and actions by government authorities, uncertainties associated with legal proceedings and negotiations, industry supply levels, competitive pricing pressures and other risks and uncertainties disclosed under the heading "Risk Factors" in the Company's short form base shelf prospectus and the registration statement on Form F-10 related to the proposed offering, the Company's Annual Information Form in respect of the year ended December 31, 2012 and the risks and uncertainties disclosed in the Management's Discussion and Analysis for the year ended December 31, 2012. Forward-looking statements and information may be identified by terms such as "may", "will", "should", "continue", "expect", "anticipate", "estimate", "believe", "intend", "plan" or "project", or similar terms or the negatives of these terms. Although we believe that the expectations reflected in the forward-looking statements and information are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. The Company's forward-looking statements and information reflect the beliefs, opinions and projections on the date the statements are made. The Company assumes no obligation to update forward-looking information should circumstances or management's estimates or opinions change, except as required by law. SOURCE IMRIS Inc.For further information: <p> Kelly McNeill<br/> Executive Vice President Finance and<br/> Administration and Chief Financial Officer<br/> IMRIS Inc.<br/> Tel: 204-480-7090<br/> Email: <a href="mailto:kmcneill@imris.com">kmcneill@imris.com </a> </p> <p> Brad Woods<br/> Director Investor Relations<br/> & Corporate Communications<br/> IMRIS Inc.<br/> Tel: 204-480-7094<br/> Email: <a href="mailto:bwoods@imris.com">bwoods@imris.com</a><br/> <br/> </p> <br/>